Business · 1 sources covering this

Amgen says drug combo cuts risk of death by 58% in patients with aggressive lung cancer

A drug from Amgen could give patients with an aggressive form of lung cancer significantly more time to live when added to an immunotherapy from AstraZeneca.

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

0 L · 0 C · 1 R

How 1 sources are covering this

CNBCLean R·1h ago
Amgen says drug combo cuts risk of death by 58% in patients with aggressive lung cancer
A drug from Amgen could give patients with an aggressive form of lung cancer significantly more time to live when added to an immunotherapy from AstraZeneca.
Read at CNBC →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/2088e813a5d75bd38d92cf213a7158ceed09f2db"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Amgen says drug combo cuts risk of death by 58% in patients with aggressive lung cancer"></iframe>

Amgen says drug combo cuts risk of death by 58% in patients with aggressive lung cancer

How 1 sources are covering this

Amgen says drug combo cuts risk of death by 58% in patients with aggressive lung cancer

More from Business

American embassies tighten security as Iran threat warnings intensify ahead of U.S. midterm elections

Why popular airplanes are getting scrapped years early

Noah Adams, Longtime Host of ‘All Things Considered,’ Has Died at 84

Retail investors are not more sophisticated than 30 years ago, says former hedge fund manager

Reader

Trust & legal

Across the network